Patents by Inventor Joan Moseman

Joan Moseman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF PTHrP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF
    Publication number: 20230277444
    Abstract: Disclosed are PTHrP analogue formulations for transdermal delivery of a therapeutically effective amount of a PTHrP analogue, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures.
    Type: Application
    Filed: November 4, 2022
    Publication date: September 7, 2023
    Applicants: Radius Health, Inc., Kindeva Drug Delivery L.P.
    Inventors: Gary Hattersley, Alan Harris, Jamal Saeh, Ehab Hamed, Kenneth Brown, Daniel Dohmeier, Joan Moseman, Ying Zhang, Lisa Dick
  • TRANSDERMAL SYSTEM FOR THE DELIVERY OF ABALOPARATIDE AND METHOD OF USE FOR TREATING OSTEOPOROSIS
    Publication number: 20210379162
    Abstract: Provided herein are methods for treating osteoporosis and increasing bone mass density, that includes administering once a day, for about 5 minutes, a transdermal patch loaded with about 300 ?g of abaloparatide, and ZnCl2 at a molar ratio of 2.2:1 of ZnCl2:abaloparatide. Also provided are the single-use transdermal patches loaded with about 300 ?g of abaloparatide, and ZnCl2 at a molar ratio of 2.2:1 of ZnCl2:abaloparatide.
    Type: Application
    Filed: August 6, 2021
    Publication date: December 9, 2021
    Applicants: Radius Health, Inc., Kindeva Drug Delivery L.P.
    Inventors: Kenneth Brown, Ehab Hamed, Alan Harris, Gary Hattersley, Joan Moseman, Jamal Saeh, Lisa Dick
  • FORMULATIONS OF ABALOPARATIDE, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF
    Publication number: 20210369816
    Abstract: Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures.
    Type: Application
    Filed: March 23, 2021
    Publication date: December 2, 2021
    Applicants: Radius Health, Inc., Kindeva Drug Delivery L.P.
    Inventors: Gary Hattersley, Alan Harris, Jamal Saeh, Ehab Hamed, Kenneth Brown, Daniel Dohmeier, Joan Moseman, Ying Zhang, Lisa Dick
  • Formulations of abaloparatide, transdermal patches thereof, and uses thereof
    Patent number: 10980862
    Abstract: Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: April 20, 2021
    Assignees: Radius Health, Inc., Kindeva Drug Delivery L.P.
    Inventors: Gary Hattersley, Alan Harris, Jamal Saeh, Ehab Hamed, Kenneth Brown, Daniel Dohmeier, Joan Moseman, Ying Zhang, Lisa Dick
  • FORMULATIONS OF ABALOPARATIDE, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF
    Publication number: 20200164045
    Abstract: Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures.
    Type: Application
    Filed: January 3, 2020
    Publication date: May 28, 2020
    Applicants: Radius Health, Inc., 3M Innovative Properties Company
    Inventors: Gary Hattersley, Alan Harris, Jamal Saeh, Ehab Hamed, Kenneth Brown, Daniel Dohmeier, Joan Moseman, Ying Zhang, Lisa Dick
  • Formulations of abaloparatide, transdermal patches thereof, and uses thereof
    Patent number: 10568937
    Abstract: Disclosed are abaloparatide formulations for transdermal delivery of a therapeutically effective amount of abaloparatide, as well as transdermal patches prepared using these formulations, methods of preparing the disclosed formulations and patches, and methods of using these formulations and patches to treat osteoporosis, osteopenia, osteoarthritis, and/or bone fracture, improve bone mineral density (BMD), improve trabecular bone score (TBS), and treat, prevent, and/or reduce bone fractures.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: February 25, 2020
    Assignees: Radius Health, Inc., 3M Innovative Properties Company
    Inventors: Gary Hattersley, Alan Harris, Jamal Saeh, Ehab Hamed, Kenneth Brown, Daniel Dohmeier, Joan Moseman, Ying Zhang, Lisa Dick
  • Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method
    Publication number: 20070287725
    Abstract: Imidazo ring compounds, (e.g. imidazo[4,5-c]pyridine, imidazo[4,5-c]quinoline, 6,7,8,9-tetrahydro imidazo[4,5-c]quinoline, and imidazo[4,5-c]naphthyridine compounds) having an isoxazole, dihydroisoxazole, or oxadiazole substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: June 17, 2005
    Publication date: December 13, 2007
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: William Miser, Joan Moseman, Tushar Kshirsagar, Philip Heppner
  • Substituted Imidazo Ring Systems and Methods
    Publication number: 20070259881
    Abstract: Imidazo ring systems, which include, for example, imidazopyridine, imidazoquinoline, 6,7,8,9-tetrahydroimidazoquinoline, imidazonaphthyridine, and 6,7,8,9-tetrahydroimidazonaphthyridine compounds substituted at the 1-position and/or the 2-position, pharmaceutical compositions containing these compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: June 17, 2005
    Publication date: November 8, 2007
    Inventors: Joseph Dellaria, Tushar Kshirsagar, Shri Niwas, William Moser, Joan Moseman, Kyle Lindstrom, Azim Celebi, John Gerster, Philip Heppner, Joshua Wurst
  • Sulfone substituted imidazo ring ethers
    Publication number: 20070155767
    Abstract: Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and 6,7,8,9-tetrahydroimidazonaphthyridines) with a sulfide-, sulfinyl-, or sulfonyl-containing ether substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
    Type: Application
    Filed: December 3, 2004
    Publication date: July 5, 2007
    Inventors: Matthew Radmer, William Moser, Joan Moseman, Joseph Dellaria
  • ETHER SUBSTITUTED IMIDAZOPYRIDINES
    Publication number: 20060252792
    Abstract: Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Application
    Filed: July 24, 2006
    Publication date: November 9, 2006
    Inventors: Joseph Dellaria, Kyle Lindstrom, Luke Dressel, Philip Heppner, John Jacobsen, Joan Moseman, William Moser, Matthew Radmer, Doris Stoermer
  • Pyrazolopyridines and analogs thereof
    Publication number: 20060100229
    Abstract: Pyrazolopyridin-4-amines, pyrazoloquinolin-4-amines, pyrazolonaphthyridin-4-amines, and 6,7,8,9-tetrahydropyrazoloquinolin-4-amines, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
    Type: Application
    Filed: April 1, 2005
    Publication date: May 11, 2006
    Inventors: David Hays, Michael Danielson, John Gerster, Shri Niwas, Ryan Prince, Tushar Kshirsagar, Philip Heppner, William Moser, Joan Moseman, Matthew Radmer, Maureen Kavanagh, Sarah Strong, Jason Bonk
  • Ether substituted imidazopyridines
    Publication number: 20050032830
    Abstract: Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Application
    Filed: August 11, 2004
    Publication date: February 10, 2005
    Inventors: Joseph Dellaria, Kyle Lindstrom, Luke Dressel, Daniel Duffy, Philip Heppner, John Jacobsen, Joan Moseman, William Moser, Matthew Radmer, Doris Stoermer, Bernhard Zimmermann